These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38494153)

  • 21. Ustekinumab for the treatment of psoriasis and psoriatic arthritis: a drug evaluation and literature review.
    Thibodaux RJ; Triche MW; Espinoza LR
    Expert Opin Biol Ther; 2018 Jul; 18(7):821-827. PubMed ID: 29949399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination Therapy of Apremilast and Biologic Agent as a Safe Option of Psoriatic Arthritis and Psoriasis.
    Metyas S; Tomassian C; Messiah R; Gettas T; Chen C; Quismorio A
    Curr Rheumatol Rev; 2019; 15(3):234-237. PubMed ID: 30499418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deficient cutaneous antibacterial competence in cutaneous T-cell lymphomas: role of Th2-mediated biased Th17 function.
    Wolk K; Mitsui H; Witte K; Gellrich S; Gulati N; Humme D; Witte E; Gonsior M; Beyer M; Kadin ME; Volk HD; Krueger JG; Sterry W; Sabat R
    Clin Cancer Res; 2014 Nov; 20(21):5507-16. PubMed ID: 25212608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low rates of vaccination among atopic dermatitis, alopecia areata, psoriasis, and psoriatic arthritis patients on biologics.
    Hren MG; Khattri S
    Arch Dermatol Res; 2024 May; 316(6):285. PubMed ID: 38796548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of therapies for skin symptoms of psoriasis in patients with psoriatic arthritis: a systematic review.
    Boehncke WH; Alvarez Martinez D; Solomon JA; Gottlieb AB
    J Rheumatol; 2014 Nov; 41(11):2301-5. PubMed ID: 25362715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The evolving landscape of biologic therapies for atopic dermatitis: Present and future perspective.
    David E; Ungar B; Renert-Yuval Y; Facheris P; Del Duca E; Guttman-Yassky E
    Clin Exp Allergy; 2023 Feb; 53(2):156-172. PubMed ID: 36653940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.
    Suárez-Fariñas M; Dhingra N; Gittler J; Shemer A; Cardinale I; de Guzman Strong C; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2013 Aug; 132(2):361-70. PubMed ID: 23777851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New Insights into the Management of Patients with Autoimmune Diseases or Inflammatory Disorders During Pregnancy.
    Tavakolpour S; Rahimzadeh G
    Scand J Immunol; 2016 Sep; 84(3):146-9. PubMed ID: 27300757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "Inflammatory skin march" in atopic dermatitis and psoriasis.
    Furue M; Kadono T
    Inflamm Res; 2017 Oct; 66(10):833-842. PubMed ID: 28620798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atopic Dermatitis-like Eruption Induced by Two Different Biologics in a Patient with Psoriatic Arthritis.
    Abe F; Mitsuyama S; Nagao E; Kimura M; Higuchi T
    Acta Derm Venereol; 2019 Dec; 99(13):1291-1292. PubMed ID: 31573661
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of psoriatic arthritis and recalcitrant skin disease with combination therapy.
    Hamilton TK
    J Drugs Dermatol; 2008 Nov; 7(11):1089-93. PubMed ID: 19110745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of remission in biologic-naive, severe psoriasis and PsA with dual anti-cytokine combination.
    Haberman RH; Castillo R; Scher JU
    Rheumatology (Oxford); 2021 Jul; 60(7):e225-e226. PubMed ID: 33369644
    [No Abstract]   [Full Text] [Related]  

  • 34. A Single-Center Experience with Dupilumab for Atopic or Psoriasiform Dermatitis in Patients with Inflammatory Bowel Disease.
    Spencer EA; Dolinger MT; Dubinsky MC
    Dig Dis Sci; 2023 Apr; 68(4):1121-1124. PubMed ID: 36064828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psoriasis and psoriatic arthritis in a patient with HIV: response to mycophenolate mofetil treatment.
    Forman SB; Higginson R; Garrett AB
    J Drugs Dermatol; 2008 Oct; 7(10):972-3. PubMed ID: 19112763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. To test or not to test? An updated evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis and psoriatic arthritis.
    Ahn CS; Dothard EH; Garner ML; Feldman SR; Huang WW
    J Am Acad Dermatol; 2015 Sep; 73(3):420-8.e1. PubMed ID: 26184440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination biologic treatment of refractory psoriasis and psoriatic arthritis.
    Cuchacovich R; Garcia-Valladares I; Espinoza LR
    J Rheumatol; 2012 Jan; 39(1):187-93. PubMed ID: 22210681
    [No Abstract]   [Full Text] [Related]  

  • 38. Gluten intake and risk of psoriasis, psoriatic arthritis, and atopic dermatitis among United States women.
    Drucker AM; Qureshi AA; Thompson JM; Li T; Cho E
    J Am Acad Dermatol; 2020 Mar; 82(3):661-665. PubMed ID: 31404570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and profiling of immunomodulatory genes in resident mesenchymal stem cells reflect the Th1-Th17/Th2 imbalance of psoriasis.
    Campanati A; Orciani M; Consales V; Lazzarini R; Ganzetti G; Di Benedetto G; Di Primio R; Offidani A
    Arch Dermatol Res; 2014 Dec; 306(10):915-20. PubMed ID: 25160906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
    Mitra A; Raychaudhuri SK; Raychaudhuri SP
    Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():21-33. PubMed ID: 25398489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.